Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).
2009
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
2005
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
2008
Clinical Update on Pentoxifylline Therapy for Diabetes-Induced Peripheral Vascular Disease
1993
Biochemical and Spectroscopic Properties of Cyanide-Insensitive Quinol Oxidase from Gluconobacter oxydans
2009 StandoutNobel
Contribution of platelets to tumour metastasis
2011 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Extraintestinal manifestations in inflammatory bowel disease
2005
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
2014
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Optimizing the safety of biologic therapy for IBD
2010
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis
2015
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A novel mathematical model quantifying drug release from lipid implants
2008
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Third Chinese National Consensus Report on the management of Helicobacter pylori infection1
(August 2007, Lushan, Jiangxi Province, China)
2008
Extracellular matrix structure
2015 Standout
An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity
2005
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Fibrin matrices: The versatile therapeutic delivery systems
2015
Crohn's disease
2016 Standout
Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?
2003
Type 2 diabetes
2017 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Perils and pitfalls of long-term effects of proton pump inhibitors
2013
From carbohydrate leads to glycomimetic drugs
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Analysis of anticancer drugs: A review
2011 Standout
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets
2016
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
2009
Clinical Guideline: Management of Gastroparesis
2012
Idarucizumab for Dabigatran Reversal
2015 Standout
Moderate and severe traumatic brain injury in adults
2008 Standout
Type 2 diabetes mellitus
2015 Standout
The FDA-approved drug sofosbuvir inhibits Zika virus infection
2016
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV‐Infected and HIV‐Uninfected Children 5 Years after Vaccination
2009
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Treatment of therapy-resistant sarcoidosis with adalimumab
2005
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy
2012
Hydrogen Peroxide: A Signaling Messenger
2006 Standout
Infectious Diseases: Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus
2007
Sequential one-pot glycosylation with glycosyl N-trichloroacetylcarbamate and trichloroacetate including dehydrative approach using 1-hydroxy sugars
2011 StandoutNobel
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
2007
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Retapamulin: A Semisynthetic Pleuromutilin Compound for Topical Treatment of Skin Infections in Adults and Children
2007
Evaluation of Environmental Contaminations and Occupational Exposures Involved in Preparation of Chemotherapeutic Drugs
2010
The extracellular matrix at a glance
2010 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Sildenafil (ViagraTM): Synthesis Step by Step and its Pharmaceutical Importance in Diabetic Patients with Erectile Dysfunction
2018
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
2006
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Biochemistry and biotechnological applications of Gluconobacter strains
2002
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Risperidone versus placebo for schizophrenia
2016
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013
A Medicinal Chemist’s Guide to Molecular Interactions
2010 Standout
Alpha-glucosidase inhibitors for type 2 diabetes mellitus
2005
Fourth C hinese National Consensus Report on the management of H elicobacter pylori infection
2013
Industry sponsorship and research outcome
2017 Standout
Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma
2007
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Danial E. Baker being referenced
Exenatide: An incretin mimetic for the treatment of type 2 diabetes mellitus
2006
Certolizumab pegol for the treatment of Crohn’s disease
2009
Inhaled dry powder insulin for the treatment of diabetes mellitus
2007
Phosphodiesterase 5 Inhibitors for Erectile Dysfunction
2005
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
2013
Intravenous proton pump inhibitors.
2006
New Drugs Approved by the FDA; Agents Pending FDA Approval; Supplemental Applications Filed by Manufacturer; Significant Labeling Changes
2007
Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.
2003
Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
2003
Adefovir dipivoxil: focus on its use in the treatment of chronic hepatitis B.
2005
Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.
2004
The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
2004
Insulin Detemir
2005
Dimethyl Fumarate
2013
Risperidone Long-Acting Injection
2004
Sofosbuvir
2014
Natalizumab: overview of its pharmacology and safety.
2007
Pentoxifylline: A New Agent for Intermittent Claudication
1985
Pneumococcal 7-Valent Conjugate Vaccine
2000
Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
2008
Rationale for using serotonergic agents to treat irritable bowel syndrome
2005
Prothrombin Complex Concentrate
2013
Tigecycline
2005
Milnacipran
2009
Miglitol: Assessment of its Role in the Treatment of Patients with Diabetes Mellitus
2000
Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity.
2002
New Drugs Approved by the FDA; Agents Pending FDA Approval; Supplemental Applications Filed by Manufacturer; Significant Labeling Changes Baker
2007